The Effect of Quadratus Lumborum (QL) Block on the Incidence of Chronic Neuropathic Pain After Re… (NCT07037992) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
The Effect of Quadratus Lumborum (QL) Block on the Incidence of Chronic Neuropathic Pain After Retroperitoneal Laparoscopic Donor Nephrectomy: A Study on Neuroinflammation and Neurophysiology
Indonesia60 participantsStarted 2025-07-01
Plain-language summary
To analyze the relationship of anterior subcostal quadratus lumborum (QL) block compared with control block on the incidence of chronic neuropathic pain at three months post-laparoscopic retroperitoneal living kidney donor.
Who can participate
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Living kidney donor candidate patients aged 18-65 years Patients with ASA physical status assessment 1-3 Patients are willing to be research subjects.
Exclusion Criteria:
* The patient was known to have a history of chronic non-cancer pain and cancer pain.
The patient had a history of preoperative laparoscopic kidney donor surgery.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Neuropathic Pain Incidence: Neuropathic Pain in 4 Questionnaire
Timeframe: 3 months after intervention
2
Neuromodulation Parameter: Degree of functional interference using Behavioral Pain Interference (BPI)
Timeframe: At 3 months after intervention
3
Chronic Pain Severity: Leeds Assesment of neuropathic symptoms and sign (LANSS) scale
Timeframe: At 3 months after intervention
4
Neuroinflammation Parameter: Serum Concentration of Toll-like Receptor 4 (TLR4)
Timeframe: At 3 months after intervention
5
Neuroinflammation Parameter: Serum Concentration of Calcitonin gene-related peptide (CGRP)
Timeframe: At 3 months after intervention
6
Neuroinflammation Parameter: Serum Concentration of Nerve Growth Factor (NGF)